BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Julphar
McKinsey
Cerilliant
Medtronic
Chinese Patent Office
Fish and Richardson
Healthtrust
Queensland Health
QuintilesIMS

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,723,303

« Back to Dashboard

Which drugs does patent 6,723,303 protect, and when does it expire?

Patent 6,723,303 protects OPTISON and is included in one NDA.

This patent has thirty-nine patent family members in twenty-seven countries.
Summary for Patent: 6,723,303
Title: Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
Abstract:Agents for use in ultrasound contrast include protein microspheres in which a gas such as perfluoropropane, perfluorobutane or perfluoropentane is contained.
Inventor(s): Quay; Steven C (Pacific Palisades, CA)
Assignee: Amersham Health, AS (Oslo, NO)
Application Number:08/466,104
Patent Claim Types:
see list of patent claims
Formulation; Use;

Drugs Protected by US Patent 6,723,303

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Ge Healthcare OPTISON albumin human INJECTABLE;INJECTION 020899-001 Dec 31, 1997 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 6,723,303

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,558,854 Ultrasound contrast media comprising perfluoropentane and perfluorohexane gas ➤ Subscribe
6,875,420 Method of ultrasound imaging ➤ Subscribe
5,393,524 Methods for selecting and using gases as ultrasound contrast media ➤ Subscribe
5,666,526 Method and system for supporting scrollable, updatable database queries ➤ Subscribe
5,409,688 Gaseous ultrasound contrast media ➤ Subscribe
5,573,751 Persistent gaseous bubbles as ultrasound contrast media ➤ Subscribe
5,558,094 Methods for using persistent gases as ultrasound contrast media ➤ Subscribe
6,620,404 Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media ➤ Subscribe
6,156,292 Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,723,303

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 191346 ➤ Subscribe
Australia 2550392 ➤ Subscribe
Australia 3995997 ➤ Subscribe
Australia 679428 ➤ Subscribe
Brazil 1100167 ➤ Subscribe
Canada 2119129 ➤ Subscribe
Canada 2273140 ➤ Subscribe
China 1054545 ➤ Subscribe
China 1073104 ➤ Subscribe
China 1264600 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Fish and Richardson
Julphar
UBS
QuintilesIMS
McKesson
Mallinckrodt
Novartis
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot